A 5-year longitudinal observational study of patients with hepatocellular carcinoma (TARGET–HCC)
Sponsor: TARGET PharmaSolutions
Enrollment status: OPEN
TThe goal of this research study is to observe any the clinical course of patients diagnosed with HCC in a "real-life" setting. Researchers are interested in collecting information and blood/tissue samples in order to develop predictors of disease progression.
- Adult patients (age > 18 years) with any history of HCC diagnosed by imaging or pathology
- Patients will be followed for up to 5 years. Medical records will be collected
- Optional Patient-Reported Outcome Survey annually
- Optional Biorepository Specimen Bank annually. Patients who agree to participate in the Biorepository Specimen Bank will be paid $25 for each blood draw.